NCT04414020 is a Phase 1 clinical trial of Progesteron in Diffuse Traumatic Cerebral Edema, sponsored by Minia University.

Who is sponsoring NCT04414020?

NCT04414020 is sponsored by Minia University.

What drugs are being tested in NCT04414020?

Interventions in NCT04414020: Progesteron.

What condition does NCT04414020 study?

NCT04414020 studies Diffuse Traumatic Cerebral Edema.

Is NCT04414020 still recruiting?

NCT04414020 is currently status unknown. Last updated 4 June 2020.

Last reviewed 2020-06-04 · How we verify

NCT04414020

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Cytoprotective Effect and Clinical Outcome of Perioperative Proesterone in Brain Tumors

Status unknown Phase 1 Last updated 4 June 2020

What this trial tests

Phase 1 trial testing Progesteron in Diffuse Traumatic Cerebral Edema in 26 participants. Status unknown.

Timeline

1 June 2020

Primary endpoint
31 August 2020

30 September 2020

Quick facts

Lead sponsor	Minia University
Phase	Phase 1
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	26
Start date	1 June 2020
Primary completion	31 August 2020
Estimated completion	30 September 2020
Sites	2 locations across Egypt

Drugs / interventions tested

Progesteron — full drug profile →

Conditions studied

Diffuse Traumatic Cerebral Edema — all drugs for Diffuse Traumatic Cerebral Edema →

Sponsor

Minia University

Who can join

Adults 20 to 65, any sex, with Diffuse Traumatic Cerebral Edema. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Neuronal injury is evident in elective craniotomy for space occupying lesions. Surgical trauma and mechanichal impact of the tumor causes neuronal injury. Neurosreroid progesterone is a neurotransmittern , trail to use in abolishing neurotoxcicty

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Minia University trials

Trials by the same sponsor.

NCT07525687 — Temporary Uterine Tourniquet Application Versus Local Myometrial Epinephrine Injection During Laparoscopic Myomectomy · NA · not yet recruiting
NCT07525674 — Vacuum Sealing Drainage (VSD) in Promoting Wound Healing and Reducing Complications in Post-Infected Obstetric and Gynec · NA · not yet recruiting
NCT07529587 — Laparoscopic Umbilico-uterine Trunk Clipping Approach in the Management of Enhanced Myometrial Vascularity · NA · not yet recruiting
NCT07500558 — Ultrasound Guided Infratemporal Sphenopalatine Ganglion Supravoltage Versus Standard Voltage Pulsed Radiofrequency for P · NA · not yet recruiting
NCT07428057 — Postoperative Hypocalcemia After Thyroidectomy · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04414020 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Minia University
Last refreshed: 4 June 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04414020.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing